Generic sodium thiosulfate IV is a hospital/clinic-administered solution used primarily as a cyanide antidote and to reduce some cisplatin toxicities. Authoritative sources in the brief list its accepted roles: as part of emergency cyanide treatment (typically given after sodium nitrite) and as an otoprotective agent for children 1 month of age and older receiving cisplatin for localized cancer. The product is supplied as an IV solution and must be administered by or under the immediate supervision of a clinician.
This review synthesizes manufacturer and clinical-reference information cited in the research brief: prescribing and patient-information summaries from Mayo Clinic, RxList, Drugs.com, and MedicineNet. Where available, I cite explicit dosing instructions (for example, RxList dosing for cyanide and cisplatin-related uses) and the safety signals these sources list, including lab monitoring recommendations.
High-level verdict: generic sodium thiosulfate is a clearly useful, well-established agent when used for its intended indications — adult cyanide treatment (RxList cites 12.5 g IV over 10–20 minutes) and pediatric otoprotection with cisplatin (Mayo Clinic notes use in children ≥1 month). Its strengths are specific, evidence-backed dosing regimens and multiple clinical applications (systemic antidote, local extravasation treatment). The downsides are substantial: risk of severe allergic reactions including anaphylaxis, electrolyte disturbances (documented sodium increase and potassium decrease), and the need for clinician oversight plus laboratory monitoring (including concern for thiocyanate toxicity noted by RxList).
Does it work for cyanide poisoning and cisplatin ototoxicity?
Yes—across authoritative sources in the brief sodium thiosulfate is listed as an established component of cyanide treatment and as a mitigation strategy for cisplatin toxicity. RxList provides concrete cyanide dosing: adult 12.5 g IV infused over 10–20 minutes, and pediatric 7 g/m² IV (maximum 12.5 g) infused over at least 10 minutes. Mayo Clinic and MedicineNet specifically note its role in reducing the risk of hearing loss in children 1 month and older receiving cisplatin for localized cancer.
For cisplatin extravasation and nephrotoxicity the brief includes practical regimens: RxList cites local extravasation administration using a 1/6 molar solution (2 mL of that solution through the cannula per 100 mg cisplatin, with 0.1 mL injections around the area up to 1 mL repeated within 3–4 hours) and a nephroprotection schedule of a 4 g/m² IV bolus followed by 12 g/m² infusion over 6 hours.
What are the main risks and lab monitoring needs?
The brief lists serious allergic reactions including anaphylaxis as a documented risk; immediate medical attention is required for signs such as difficulty breathing, swelling of the face or tongue, hives, or rapid heartbeat (Drugs.com). Routine monitoring is recommended: the drug may increase serum sodium and decrease potassium, and clinicians should monitor electrolytes and watch for muscle weakness or seizures.
Other reported adverse effects from the brief include black, tarry stools, bone pain, chills, cough, decreased urine, dizziness, dry mouth, fast heartbeat, fever, high blood pressure, and increased thirst (Drugs.com). RxList also warns to monitor for thiocyanate toxicity during some dosing regimens.
How is it prepared and administered in practice?
Sources in the brief provide actionable preparation details: RxList gives an example for preparing a 1/6 molar solution (mixing 4 mL of 10% solution with 6 mL sterile water or 1.6 mL of 25% solution with 8.4 mL sterile water). For cyanide, the adult IV dose commonly cited is 12.5 g infused over 10–20 minutes; pediatrics use body-surface-area dosing capped at 12.5 g.
Administration must be clinician-controlled: the Mayo Clinic explicitly states the medicine is to be given only by or under immediate supervision of your doctor. For cisplatin extravasation the brief lists local injection technique volumes and timing (2 mL 1/6 M per 100 mg cisplatin through cannula, with small-volume injections up to 1 mL repeated within 3–4 hours).
Logistics, monitoring, and clinical context
Clinics should be prepared for immediate management of allergic reactions and have lab capability to check electrolytes and, when used in prolonged regimens, to monitor for thiocyanate levels as advised in prescribing references. Drugs.com advises regular physician follow-up and blood tests to ensure therapy is working and to detect unwanted effects.
Because generic sodium thiosulfate is available as a solution, hospitals generally stock or compound it; however, dosing regimens vary by indication (antidote vs cisplatin protection vs extravasation management), so institutional protocols should mirror the specific regimens cited in prescribing references.
When the drug's risks or logistics reduce its suitability
Key limitations from the brief are the potential for life-threatening allergic reactions, documented electrolyte changes (increased sodium, decreased potassium), and the need for supervised IV administration with lab monitoring—factors that limit outpatient or unsupervised use.
Another limitation is the need for precise preparation for some indications (e.g., 1/6 molar solution for extravasation), which demands trained staff and access to sterile compounding procedures; RxList also notes monitoring for thiocyanate toxicity in certain regimens.
Pros & Cons
- ✅ Listed, evidence-backed cyanide antidote dosing: adult 12.5 g IV over 10–20 minutes (RxList).
- ✅ Documented otoprotection use in children aged 1 month and older receiving cisplatin (Mayo Clinic / MedicineNet).
- ✅ Specific regimens for cisplatin nephroprotection and extravasation are provided (e.g., 4 g/m² bolus + 12 g/m² over 6 hours; 1/6 M local solution for extravasation) (RxList).
- ✅ Available as an IV solution that can be prepared into a 1/6 molar solution for local use (RxList preparation instructions).
- ✅ Can be used sequentially with sodium nitrite as part of established cyanide-treatment protocols (MedicineNet / RxList).
- ❌ Risk of severe allergic reactions including anaphylaxis; requires immediate medical management if it occurs (Drugs.com).
- ❌ Can increase serum sodium and decrease potassium—requires electrolyte monitoring and may cause muscle weakness or seizures (Drugs.com).
- ❌ Administration must be clinician-supervised with blood tests and possible thiocyanate monitoring, limiting use to hospital/clinical settings (Mayo Clinic, RxList).
- ❌ Preparation complexity for some indications (1/6 molar solutions, BSA-based dosing) requires trained staff and sterile compounding (RxList).
How It Compares to the Competition
- Pedmark (sodium thiosulfate branded formulation) — Branded sodium thiosulfate indicated specifically for pediatric cisplatin otoprotection; same active agent but with brand-specific labeling and protocols.
- Sodium nitrite (component of cyanide antidote regimen) — Used sequentially with sodium thiosulfate in cyanide poisoning regimens; sodium nitrite provides complementary mechanism and is part of the cited protocol.
- Hospital-compounded generic sodium thiosulfate solutions — Locally prepared formulations used in many centers—same active ingredient but variable preparation and concentration that require institutional protocols.
Who Should Buy This & Who Should Skip It
Buy it if: Hospitals, emergency departments, and oncology infusion centers that need an established cyanide antidote and a clinically supported option to reduce cisplatin ototoxicity in children (≥1 month). Clinical teams that can provide supervised IV administration and laboratory monitoring will get the most reliable, safe use.
Skip it if: Outpatient clinics or clinics without immediate clinician supervision, rapid access to emergency resuscitation, or lab monitoring should avoid stocking unsupervised supplies—this drug requires acute-care oversight. Providers seeking an antidote without capacity for electrolyte or thiocyanate monitoring should use alternative institutional protocols.
Search Purchase Options
Use these links to search for Generic sodium thiosulfate IV formulations on trusted marketplaces. The links open in new tabs; if you buy through them, we may earn a commission at no extra cost to you.
* Affiliate links: you pay the same price either way.